1-3 of 3
Manal M. Hassan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA

Free
Ahmed O. Kaseb, Nora S. Sánchez, Shiraj Sen, Robin K. Kelley, Benjamin Tan, Andrea G. Bocobo, Kian H. Lim, Reham Abdel-Wahab, Marc Uemura, Roberto Carmagnani Pestana, Wei Qiao, Lianchun Xiao, Jeffrey Morris, Hesham M. Amin, Manal M. Hassan, Asif Rashid, Kimberly C. Banks, Richard B. Lanman, AmirAli Talasaz, Kenna R. Mills-Shaw, Bhawana George, Abedul Haque, Kanwal P.S. Raghav, Robert A. Wolff, James C. Yao, Funda Meric-Bernstam, Sadakatsu Ikeda, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6107–6118.
https://doi.org/10.1158/1078-0432.CCR-18-3341
Published: 15 October 2019
View article titled, Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Open the PDF for Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA in another window
Includes: Supplementary data
Journal Articles

Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma

Free
Bo Hwa Sohn, Jae-Jun Shim, Sang-Bae Kim, Kyu Yun Jang, Soo Mi Kim, Ji Hoon Kim, Jun Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang-Cheol Kim, Woojin Jeong, Sung Soo Kim, Eun Sung Park, Jeonghoon Heo, Yoon Jun Kim, Dae-Ghon Kim, Sun-Hee Leem, Ahmed Kaseb, Manal M. Hassan, Minse Cha, In-Sun Chu, Randy L. Johnson, Yun-Yong Park, Ju-Seog Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (5): 1256–1264.
https://doi.org/10.1158/1078-0432.CCR-15-1447
Published: 29 February 2016
View article titled, Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma
Open the PDF for Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer

Free
Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Kimberly A. Waugh, Ashraful M. Hoque, Adam I. Frome, Sandeep Lahoti, Lee Ellis, J. Nicolas Vauthey, Steven A. Curley, Isac I. Schnirer, Isaac Raijman
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3375–3380.
Published: 01 November 2001
View article titled, Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer
Open the PDF for Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer in another window